Close Menu

NEW YORK (360Dx) – Roche announced today that it has received US Food and Drug Administration approval for its Cobas c 513 analyzer and Tina-quant HbA1c Gen. 3 assay.

HbA1c is a form of hemoglobin used as measure of average plasma glucose concentration in the management of diabetes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.